Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. [electronic resource] by
- Jones, Stephen
- Holmes, Frankie Ann
- O'Shaughnessy, Joyce
- Blum, Joanne L
- Vukelja, Svetislava J
- McIntyre, Kristi J
- Pippen, John E
- Bordelon, James H
- Kirby, Robert L
- Sandbach, John
- Hyman, William J
- Richards, Donald A
- Mennel, Robert G
- Boehm, Kristi A
- Meyer, Wally G
- Asmar, Lina
- Mackey, Daniel
- Riedel, Stefan
- Muss, Hyman
- Savin, Michael A
Producer: 20090325
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|